Spectranetics to Participate in Upcoming Investor Conferences
November 04 2015 - 4:08PM
The Spectranetics Corporation (Nasdaq:SPNC) today announced that
its management will be participating in two upcoming investor
conferences.
Spectranetics management is scheduled to present at the 2015
Stifel Healthcare Conference in New York City on Wednesday,
November 18, 2015 at 11:45am ET.
Spectranetics management is also scheduled to present at the
2015 Canaccord Genuity Medical Technology and Diagnostics Forum in
New York City on Thursday, November 19, 2015 at 11:00am ET.
Interested parties can access the live audio webcast for each
event at http://www.spectranetics.com. An archived presentation of
each webcast will be available on the website for 30 days.
About Spectranetics
The Spectranetics Corporation develops, manufactures, markets
and distributes medical devices used in minimally invasive
procedures within the cardiovascular system. The Company's products
are sold in over 65 countries and are used to treat arterial
blockages in the heart and legs and in the removal of pacemaker and
defibrillator leads.
The Company's Vascular Intervention (VI) products include a
range of laser catheters for ablation of blockages in arteries
above and below the knee, the AngioSculpt® scoring balloon used in
both peripheral and coronary procedures, and the Stellarex
drug-coated balloon peripheral angioplasty platform, which received
European CE mark approval in December 2014. The Company also
markets support catheters to facilitate crossing of peripheral and
coronary arterial blockages, and retrograde access and guidewire
retrieval devices used in the treatment of peripheral arterial
blockages, including chronic total occlusions. The Company markets
aspiration and cardiac laser catheters to treat blockages in the
heart.
The Lead Management (LM) product line includes excimer laser
sheaths, dilator sheaths, mechanical sheaths and accessories for
the removal of pacemaker and defibrillator cardiac leads.
For more information, visit www.spectranetics.com.
CONTACT: Investor Relations Contacts
Guy Childs
Investor.relations@spnc.com
(719) 447-2415
Lynn Pieper
Investor.relations@spnc.com
(415) 202-5678
The Spectranetics Corp. (MM) (NASDAQ:SPNC)
Historical Stock Chart
From Mar 2024 to Apr 2024
The Spectranetics Corp. (MM) (NASDAQ:SPNC)
Historical Stock Chart
From Apr 2023 to Apr 2024